BEST COLLABORATION CRITERIA
Current business models reveal a number of promising collaborations of many configurations: company–company, supplier–supplier, company–supplier, academic testing labs working with suppliers and/or companies, contract-service providers partnering to become drug developers . . . and so on. With concerns about the long-term viability of supply chains, creative approaches to partnering are helping to accelerate drug development and mitigate associated risks. Nominate the companies or groups that have formed in the past year and whose story you find especially significant; or whose ongoing collaboration has yielded a significant benefit or innovation in this past 18 months.